Do all test results lead to actionable treatment options?
Each individual cancer is unique and test results vary depending on the tumor type. When applicable, test results may help identify:
- A therapy approved to treat your specific tumor type and shown to be effective in targeting one or more of the alterations found by the test
- A therapy approved in another tumor type but possibly effective in targeting one or more of the genomic alterations found by the test
- A clinical trial evaluating therapies under development which may work by targeting an alteration found by the test
Does insurance cover my test?
Foundation Medicine accepts all insurance plans; however, we are currently not in-network providers with all insurance plans. If you are uninsured, or if you have insurance and cannot afford the applicable out-of-pocket cost, you have options. You can fill out a financial assistance application to determine upfront what your maximum out-of-pocket expense might be. Payment plans may also be available. Please contact our Client Services Team for more detailed information. Learn more about our Medicare Compliance policy.
Do the tests apply to all types of cancer?
Our suite of comprehensive genomic profiling (CGP) assays can help deliver meaningful molecular insights across the broad spectrum of tumor types including but not limited to:
FoundationOne CDx: Solid tumors, including Non-Small Cell Lung (NSCLC), Colorectal, Breast, Ovarian, and Melanoma
FoundationOne® Heme: Leukemias, Myelodysplastic Syndrome, Myeloproliferative Neoplasm, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, and Sarcomas
FoundationOne®Liquid: Solid tumors, including Lung, Breast, Prostate, Gastro-Intestinal, Melanoma, and Brain
How does genomic testing differ from genetic testing?
Genetic testing detects hereditary (inherited from parents) alterations in DNA while genomic testing detects acquired (over the course of a lifetime) alterations in DNA. Acquired alterations are responsible for the majority of cancers and may impact tumor growth, spread, and response to therapy.
When should I get tested?
Foundation Medicine® tests for solid tumor cancers are generally used for more advanced disease whereas Foundation Medicine tests for hematologic malignancies and soft tissue sarcomas can also be used at diagnosis, for prognostication, and to guide overall clinical management. Talk with your doctor to see if our tests are right for you.